tiprankstipranks
Advertisement
Advertisement
MaxCyte Reports Lower 2025 Revenue, Provides 2026 Outlook
PremiumCompany AnnouncementsMaxCyte Reports Lower 2025 Revenue, Provides 2026 Outlook
27d ago
MaxCyte sees FY26 revenue $30M-$32M, consensus $38.41M
Premium
The Fly
MaxCyte sees FY26 revenue $30M-$32M, consensus $38.41M
27d ago
MaxCyte reports Q4 EPS (9c), consensus (8c)
Premium
The Fly
MaxCyte reports Q4 EPS (9c), consensus (8c)
27d ago
MaxCyte management to meet with Craig-Hallum
PremiumThe FlyMaxCyte management to meet with Craig-Hallum
5M ago
MaxCyte CFO Douglas Swirsky to transition out of role
Premium
The Fly
MaxCyte CFO Douglas Swirsky to transition out of role
5M ago
MaxCyte reiterates FY25 revenue guidance flat to down 10% vs. last year
Premium
The Fly
MaxCyte reiterates FY25 revenue guidance flat to down 10% vs. last year
5M ago
MaxCyte enters platform license agreement with Moonlight Bio
PremiumThe FlyMaxCyte enters platform license agreement with Moonlight Bio
7M ago
MaxCyte Announces Major Workforce Reduction Plan
Premium
Company Announcements
MaxCyte Announces Major Workforce Reduction Plan
7M ago
MaxCyte Chief Commercial Officer Departs Amid Severance Agreement
Premium
Company Announcements
MaxCyte Chief Commercial Officer Departs Amid Severance Agreement
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100